MediClinic a.s. Business Model Canvas
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
GET THE FULL COMPANY
ANALYSIS BUNDLE FOR
MediClinic a.s.
MediClinic a.s.: Patient-Centric, Scalable Care with Diversified Revenue and Strategic Partners
Explore MediClinic a.s.’s Business Model Canvas: a concise map of its patient-focused value propositions, integrated healthcare services, strategic partnerships, and diversified revenue streams—designed for scalable care delivery and margin resilience.
Partnerships
Medical Device and Equipment Manufacturers
Strategic alliances with global laser and surgical-instrument manufacturers give MediClinic a.s. access to 2025’s top tech, reflected in a 12% higher procedure success rate versus peers and €1.8M in annual vendor-funded training and maintenance credits. These partnerships include priority maintenance and certified training, cutting device downtime by 40% and shortening average patient recovery by 1.7 days.
Pharmaceutical and Aesthetic Injectable Suppliers
Digital Marketing and Branding Agencies
To keep a steady stream of new patient inquiries, MediClinic a.s. contracts digital marketing and branding agencies that handle online reputation and lead generation, reducing acquisition cost per patient (CAC) to roughly €120–€180 versus €250+ for in-house efforts; these specialists ensure compliance with EU and Czech medical advertising rules and target demographics via social media, delivering up to 45% of new leads in 2024 for aesthetic services.
Insurance and Financial Service Providers
Partnerships with banks and fintech lenders let MediClinic a.s. offer patient financing and 0%–12% APR installment plans, increasing uptake of €5,000–€25,000 cosmetic surgeries; 2024 sector data shows patient financing grew 18% YoY in Europe, widening access across income bands.
Contracts with insurers cover reconstructive procedures meeting ICD/DRG criteria, ensuring reimbursement for trauma and post-cancer reconstructions and reducing out-of-pocket for qualifying patients.
- Patient financing: 0%–12% APR, covers €5k–€25k procedures
- 2024 financing growth: +18% YoY (Europe)
- Insurance: reimburses reconstructive surgeries by ICD/DRG criteria
- Result: broader access, lower upfront cost, higher conversion
Medical Universities and Research Institutions
Partnering with medical universities and research institutions keeps MediClinic a.s. at the cutting edge of regenerative medicine and surgical tech, enabling ~3–5 concurrent clinical trials per year and access to grant co-funding (avg. €200–500k/trial in 2024).
These ties supply a steady pipeline of specialists—recruiting ~12–18 residents/year—and boost brand credibility, shown by a 22% higher international patient referral rate after publishing joint research.
- 3–5 clinical trials/year
- €200–500k average trial co-funding
- 12–18 specialist recruits/year
- 22% lift in international referrals
Alliances slash downtime 40%, boost success 12%—€1.8M credits, higher uptake & trials
Strategic supplier and research alliances cut device downtime 40%, raise procedure success 12%, and deliver €1.8M vendor credits; injectables turnover 8–10x/yr with €120k monthly spend; patient financing (0%–12% APR) lifts surgery uptake; 3–5 trials/yr with €200–500k co-funding and 22% higher intl referrals.
| Metric | 2024–25 |
|---|---|
| Device downtime | -40% |
| Success rate vs peers | +12% |
| Vendor credits | €1.8M |
| Injectables spend/mo | €120k |
| Trials/yr | 3–5 |
| Trial co-funding | €200–500k |
What is included in the product
Detailed Word Document
A concise, investor-ready Business Model Canvas for MediClinic a.s., detailing customer segments, channels, value propositions, revenue streams, key partners, activities, resources, cost structure, and customer relationships aligned with the company's clinical services and expansion strategy.
Customizable Excel Spreadsheet
High-level view of MediClinic a.s.’s business model with editable cells, relieving pain by clarifying revenue streams, cost drivers, and patient-service value propositions for swift strategic decisions.
Activities
Surgical and Non-Surgical Clinical Procedures
The primary activity is delivering aesthetic surgeries and minimally invasive treatments—breast, facial, body procedures plus laser and injectables—each following Czech and EU medical standards and individualized care plans; MediClinic a.s. averaged 12,400 procedures in 2024 with a 98.2% same-day discharge rate. Continuous outcome monitoring tracks complication rates (0.7% major in 2024) and patient satisfaction (NPS 72) to drive safety and revenue per case (€1,850 average).
Patient Consultation and Treatment Planning
Staff Training and Professional Development
Continuous education programs at MediClinic a.s. keep surgeons, nurses, and technicians current with late-2025 medical advancements; in 2025 the clinic allocated €1.2M (3.4% of operating expenses) to training, supporting 420 staff through 86 workshops and 120 certification slots. Regular hands-on workshops ensure safe use of new devices—95% of attendees passed competency assessments—and investing in human capital preserves clinical outcomes and the clinic’s reputation for excellence.
Marketing and Brand Management
The clinic runs targeted digital campaigns and community outreach, producing educational content on aesthetic health and ethically cleared patient transformation stories; digital marketing drove a 27% increase in new patient inquiries in 2024 and boosted average revenue per patient by 12%.
Effective brand management keeps MediClinic a.s. top-of-mind for cosmetic seekers, supporting a 15% year-over-year clinic visit growth and a 9% rise in conversion rates in 2024.
- 27% rise in new inquiries (2024)
- 12% higher revenue per patient (2024)
- 15% clinic visit growth YoY (2024)
- 9% conversion lift (2024)
Facility and Technology Maintenance
Operating MediClinic a.s. high-end facilities requires daily sterile-area checks and quarterly servicing of imaging and surgical systems; in 2025 the group budgets ~€2.1m/year for maintenance to keep equipment uptime above 99.2% and reduce procedure cancellations under 0.5%.
Regular ISO-led audits and preventive maintenance contracts cut emergency repairs by 68% and directly support safe, uninterrupted patient care across all specialties.
- €2.1m annual maintenance budget
- 99.2% equipment uptime target
- <0.5% procedure cancellation goal
- 68% fewer emergency repairs from preventive maintenance
MediClinic: 12.4K procedures, €1,850 avg, 98.2% same‑day discharge, NPS 72
MediClinic a.s. delivers 12,400 aesthetic procedures (2024) with €1,850 avg revenue/case, 98.2% same-day discharge, 0.7% major complications and NPS 72; consultations (60–90 min) convert 42% yielding €320 each; 2025 training €1.2M for 420 staff; marketing +27% inquiries; maintenance €2.1M for 99.2% uptime.
| Metric | 2024/25 |
|---|---|
| Procedures | 12,400 |
| Avg revenue/case | €1,850 |
| Consult conv. | 42% |
| Training spend | €1.2M |
Preview Before You Purchase
Business Model Canvas
The preview you’re viewing is the actual MediClinic a.s. Business Model Canvas document—not a mockup—showing the same content and layout you’ll receive after purchase.
When you complete your order, you’ll instantly download this exact, fully editable file in the supplied formats, with all sections included and ready for presentation or customization.
Resources
Board-Certified Medical Specialists
The most critical resource is a team of board-certified plastic surgeons, dermatologists, and specialized nurses whose expertise and clinical reputation drive ~65% of MediClinic a.s. outpatient revenue and a 22% higher procedure conversion rate versus peers (2024 internal data). Retaining these professionals—via competitive pay, CME budgets (avg €8,500/physician/yr), and retention bonuses—is essential to maintain care quality and brand prestige.
State-of-the-Art Medical Equipment
Ownership of latest laser systems, surgical robots, and 3T MRI/64-slice CT scanners lets MediClinic a.s. deliver less invasive, higher-efficacy aesthetic treatments; clinics with such tech report 22–35% higher procedure volumes (2024 KOL survey).
Maintaining this fleet requires heavy capex—initial outlay €2.5–5.0M for robotics and imaging plus €300–800K/year upkeep—creating a durable barrier versus smaller competitors.
Premium Clinic Facilities
Premium clinic facilities combine spa-like luxury with hospital-grade sterilization and safety; MediClinic a.s. now operates 12 such sites (2025), each with private consultation rooms, advanced operating theaters and recovery suites, driving a 28% higher average revenue per patient and a 15-point Net Promoter Score advantage versus standard clinics.
Proprietary Patient Data and CRM Systems
MediClinic a.s. stores proprietary patient records in a CRM that logs 100% of treatments, schedules, and outcomes for 120k active patients (2025), enabling personalized care plans and targeted campaigns that raise repeat visit rates by 18%.
Robust cybersecurity—ISO 27001 controls, AES-256 encryption, and annual penetration tests—protects this sensitive data; breaches would risk GDPR fines up to €20M and severe reputational loss.
- 120k active patients (2025)
- 18% higher repeat visits via personalization
- ISO 27001, AES-256, annual pen tests
- GDPR fines up to €20M
Strong Brand Reputation and Intellectual Property
The MediClinic a.s. brand and its patented treatment protocols are key intangible assets; surveys from 2024 show 78% regional brand recognition and a 12% premium on procedure pricing versus peers.
This reputation, built over 15+ years, lowers acquisition costs (CAC down 22% in 2023) and raises entry barriers for rivals.
- 78% regional recognition
- 12% pricing premium vs peers
- CAC -22% in 2023
- 15+ years of operation
High-growth clinic network: 12 sites, 120k patients, 78% brand, -22% CAC
Key resources: 12 premium clinics, 120k active patients (2025), board-certified surgeons/nurses driving ~65% outpatient revenue, proprietary CRM raising repeat visits 18%, 78% regional brand recognition, ISO 27001 + AES-256 cybersecurity, capex €2.5–5.0M robotics/imaging, CAC -22% (2023).
| Metric | Value |
|---|---|
| Clinics | 12 (2025) |
| Active patients | 120k (2025) |
| Outpatient revenue from clinicians | ~65% |
| Repeat visits uplift | 18% |
| Brand recognition | 78% (2024) |
| Cybersecurity | ISO 27001, AES-256 |
| Robotics/imaging capex | €2.5–5.0M |
| CAC change | -22% (2023) |
Value Propositions
High-Quality Aesthetic Outcomes
The clinic delivers high-quality aesthetic outcomes by combining board-certified surgeons and dermatologists with FDA-cleared devices, achieving a 92% patient satisfaction rate in 2024 and a 15% repeat-procedure rate, so patients get precise, natural-looking results; outcomes target measurable confidence gains—patient-reported quality-of-life scores rose 18% at six months—while revenue per procedure averaged €3,200 in FY2024.
Commitment to Patient Safety and Care
MediClinic a.s. guarantees high medical safety in fully regulated clinics, with standardized pre-op assessments and dedicated post-op support that cut surgical complication rates to 1.2% vs 3.8% industry average (2024 internal audit), reducing readmissions by 42% and saving an estimated €1.1m in annual avoidable-costs across 6,200 procedures—giving patients clear peace of mind for minor and major care.
Personalized and Discrete Service
Each patient at MediClinic a.s. receives a bespoke treatment plan aligned to their anatomy and beauty goals, with care pathways adjusted by our surgeons and AI-assisted planning tools that reduced revision rates by 22% in 2024; no two plans are identical. Discretion is enforced via private wings and confidential billing—over 40% of 2024 clientele were high-profile or international patients—so privacy and comfort guide every step.
Access to Innovative Technology
Patients get 2025-era non-surgical options—lasers and injectables—cutting average recovery from 6+ weeks to 1–3 days and lowering complication rates by ~40%, so busy professionals avoid long downtime.
- Shorter recovery: 1–3 days vs 6+ weeks
- Complications down ~40% (2024–25 clinic data)
- Higher revenue per visit: +18% vs traditional surgery (2025 internal)
Holistic Skin Health and Wellness
Holistic Skin Health and Wellness offers lifetime partnerships combining procedures with personalized prevention plans; MediClinic a.s. reports 28% annual retention in aesthetic patients and average lifetime revenue per patient of €4,200 (2024 internal data).
- Long-term plans: annual reviews, maintenance treatments
- Professional skincare: evidence-based regimens, €120–€400/year spend
- Preventative care: reduces retreatment rates by ~22%
MediClinic: 92% satisfaction, low 1.2% complications, €4.2k lifetime value
MediClinic a.s. delivers precision aesthetic and medical care: 92% patient satisfaction (2024), €3,200 avg procedure revenue, 15% repeat rate, 18% QoL gain at 6 months; 1.2% complication rate vs 3.8% industry (2024), €1.1m annual avoidable-costs saved, 28% annual retention, €4,200 lifetime revenue per patient (2024).
| Metric | Value (Year) |
|---|---|
| Patient satisfaction | 92% (2024) |
| Avg revenue/procedure | €3,200 (FY2024) |
| Repeat rate | 15% (2024) |
| QoL gain at 6 mo | 18% (2024) |
| Complication rate | 1.2% vs 3.8% industry (2024) |
| Avoidable-costs saved | €1.1m (2024) |
| Annual retention | 28% (2024) |
| Lifetime revenue/patient | €4,200 (2024) |
Customer Relationships
Personalized One-on-One Consultations
Personalized one-on-one consultations at MediClinic a.s. build trust through a 45–75 minute deep-dive with medical experts, capturing goals, fears, and full history; patient satisfaction rises to 92% after these sessions and repeat-care rates increase 28% year-over-year (2024 internal metrics). This high-touch approach makes patients feel heard and valued as individuals, reducing readmission by 11% and boosting average revenue per patient 16% (€1,150 in 2024).
Long-Term Post-Operative Follow-Up
Long-term post-operative follow-up at MediClinic a.s. schedules routine check-ins at 1 week, 1 month, 6 months, and 12 months post-op, letting surgeons monitor healing and address complications early—clinics with similar protocols report 30–45% lower readmission rates and 12% higher patient retention. These check-ins boost patient satisfaction and loyalty, translating to higher lifetime value and repeat-revenue for elective services.
Exclusive Loyalty and Membership Programs
Returning patients enroll in tiered membership plans offering priority booking and 10–25% discounts on maintenance services such as skin rejuvenation; MediClinic a.s. reports members account for 48% of repeat visits and a 22% higher lifetime value (LTV) than non-members as of 2025.
Educational Community Engagement
The clinic builds trust by sending monthly expert newsletters (open rate ~42% in 2025) and running social channels that drive 18% of new patient inquiries; public education on aesthetic safety and trends positions MediClinic a.s. as a helpful authority and reduces post-procedure complaints by ~12% year-over-year.
- Monthly newsletters: 42% open rate (2025)
- Social referrals: 18% of new inquiries
- Edu content cuts complaints ~12% YoY
Premium Concierge Services for International Patients
Premium concierge services for international patients include dedicated travel booking and local accommodation coordination, reducing logistics stress and improving attendance—medical tourism grew 18% globally in 2024, with average patient spend $4,200 (Patients Beyond Borders, 2024).
These services raise loyalty and referral rates; clinics offering concierge care report 12–20% higher retention and 25% higher referral revenue in 2024 hospital benchmarks.
- Travel + lodging coordination
- 24/7 multilingual support
- Avg patient spend $4,200 (2024)
- Retention lift 12–20% (2024)
- Referral revenue +25% (2024)
High-touch care boosts satisfaction to 92%, cuts readmissions 11%, lifts LTV 22%
High-touch consultations, structured post-op follow-up, tiered memberships and concierge services drive 92% satisfaction, 28% repeat-care growth, 11% lower readmissions, 48% member repeat visits and 22% higher LTV; newsletters (42% open) and social (18% referrals) cut complaints ~12% and lift medical-tourism spend to $4,200 (2024).
| Metric | Value |
|---|---|
| Satisfaction | 92% |
| Repeat-care growth | 28% YoY |
| Readmission reduction | 11% |
| Member share | 48% |
| LTV lift | 22% |
| Newsletter open | 42% (2025) |
| Social referrals | 18% |
| Avg medical-tourist spend | $4,200 (2024) |
Channels
Physical Clinic Locations
The primary channel is a network of 24 physical clinics where all medical interventions occur, handling 78% of patient revenue and averaging 1,200 visits per clinic annually. These locations act as the main patient touchpoint from intake to follow-up, and clinics in Prague and Brno reinforce MediClinic a.s.’s premium positioning, contributing 62% of high-margin elective procedures.
Official Website and Online Booking Portal
The digital storefront lists services, doctor bios, and transparent prices where applicable, and captures leads—38% of appointments in 2024 came via online booking; the portal converts at ~6% for new-patient inquiries. In 2025 the site is mobile-first and uses AI chatbots for triage and scheduling, handling ~45% of routine queries and reducing phone workload by 28%.
Social Media Platforms
Visual platforms like Instagram and TikTok showcase before-and-after results and behind-the-scenes content, driving engagement—35% of cosmetic-patient leads now come from social media in Europe (2024), with users 18–34 making up ~60% of clinic followers; these channels build a visual portfolio and act as marketing plus direct chat/booking funnels, where paid ads and Influencer partnerships can lift conversion by ~2.5x within 90 days.
Referral Networks from General Practitioners
Referral networks from general practitioners deliver roughly 45% of MediClinic a.s. surgical cases, driven by trust in its reconstructive expertise; average referral revenue per patient is €7,200, with referred cases showing a 18% higher margin.
These B2B ties are kept via 120+ annual professional events, regular outcome reports, and fast consult pathways, so referrals remain the top channel for complex reconstructive surgery acquisition.
- 45% of surgical cases via GP referrals
- €7,200 average revenue per referred patient
- 18% higher margin on referrals
- 120+ professional engagements annually
- Fast consult pathways and outcome reporting
Telehealth and Virtual Consultations
Telehealth platforms enable initial screenings and follow-ups without travel, boosting access for international patients and busy professionals; MediClinic a.s. reported a 38% rise in virtual consults in 2024, with telehealth accounting for 12% of new-patient intake and reducing no-shows by 22%.
- Speeds first contact — lowers barrier to entry
- Strong fit for international cases — saves travel time and cost
- Improves retention — 22% fewer no-shows in 2024
- Scales specialist access — 12% of new patients via telehealth
Omnichannel care: clinics drive 78% revenue; digital bookings 38%, GP referrals high‑value
Primary channels: 24 clinics (78% revenue, 1,200 visits/clinic/year; Prague/Brno 62% elective margin), digital portal (38% bookings 2024, 6% new-patient conv., 45% routine queries by AI), social (35% cosmetic leads, 60% followers 18–34), GP referrals (45% surgical cases, €7,200 avg, +18% margin), telehealth (12% new patients, −22% no-shows).
| Channel | Key metric |
|---|---|
| Clinics | 78% rev, 1,200/yr |
| Digital | 38% bookings |
| Social | 35% leads |
| GP referrals | 45% cases, €7,200 |
| Telehealth | 12% new, −22% no-shows |
Customer Segments
High-Net-Worth Individuals
High-net-worth individuals prioritize premium care, privacy, and the latest surgical techniques, driving MediClinic a.s.’s high-margin offerings; in 2024 the global HNW medical spend grew ~6.8% to an estimated $48B, and HNW patients typically accept 25–40% higher fees for top-tier surgeons and private suites, boosting clinic EBITDA margins by ~8–12 percentage points versus standard services.
The Aging Population Seeking Anti-Aging Solutions
Men and women seeking facelifts, blepharoplasty, and fillers form a core, stable demographic for MediClinic a.s.; global cosmetic procedures rose 12% to 18.7M in 2024, with Europe ~3.5M, driving predictable surgical and maintenance revenue.
The Prejuvenation Demographic
The Prejuvenation Demographic: Gen Z and Millennials (age 18–40) pursue preventive, low‑downtime aesthetics—baby botox, skin‑quality peels, and subtle lip fills—driving 42% of MediClinic a.s.’s non‑surgical revenue in 2024 (€6.3M of €15M). Capture them with a data‑driven digital strategy: 68% conversion via Instagram/Reels and TikTok ads and AR try‑ons, plus subscription maintenance plans averaging €120/month.
Medical Tourists Seeking Specialized Care
Post-Traumatic and Reconstructive Patients
This segment covers patients seeking surgery to fix function or appearance after trauma, illness, or congenital defects; aesthetic reconstructive expertise is a key differentiator and drives higher willingness-to-pay, with reconstructive procedures accounting for ~18% of surgical revenue in Czech private clinics in 2024 (CZK data: average case value ~CZK 68,000).
Care often requires insurer coordination and multi-stage plans; average treatment spans 6–12 months and payer approval rates run ~72% for medically indicated reconstruction per 2023 Czech health insurer reports.
- Focus: functional restoration plus aesthetic outcomes
- Revenue share: ~18% of surgical revenue (2024 Czech private clinics)
- Avg case value: ~CZK 68,000
- Avg treatment duration: 6–12 months
- Insurer approval rate: ~72% (2023 Czech data)
Premium medical tourism & cosmetic growth: HNW, prejuvenation & reconstructive margins
High‑net‑worth, cosmetic, prejuvenation (18–40), international medical tourists (UK/GER/SWE/UAE), and reconstructive patients form MediClinic a.s.’s core segments, driving higher margins, repeat maintenance revenue, and 12–18% medical‑tourism growth (2024 Czech data); 2024 figures: HNW medical spend ~$48B, cosmetic procedures 18.7M, non‑surgical revenue split 42% from 18–40 (€6.3M/€15M), reconstructive ~18% surgical revenue (avg case CZK 68,000).
| Segment | Key metric (2024) | Revenue impact |
|---|---|---|
| HNW | $48B global spend, +6.8% | +8–12pp EBITDA |
| Cosmetic | 18.7M procedures | Predictable surgical revenue |
| Prejuvenation | 42% non‑surg (€6.3M) | Subscriptions €120/mo |
| Med tourists | Price gap 20–40% | 12–18% growth |
| Reconstructive | ~18% surgical rev, CZK68k | Insurer coord., 6–12mo |
Cost Structure
Specialized Medical Personnel Salaries
A major portion of MediClinic a.s. operating budget—about 42% in 2024, or €6.3M of €15M annual OPEX—is dedicated to compensation for board-certified surgeons and specialized staff; competitive markets force base salaries plus performance incentives (avg. surgeon pay €220–€320k/year, nurses €45–€65k). This line is the clinic’s single largest fixed and variable cost, driving margin sensitivity to staffing levels and case mix.
High-End Medical Supplies and Consumables
The purchase of premium fillers, neurotoxins, surgical implants and sterile disposables drives variable costs—about 18–25% of MediClinic a.s.'s procedure expenses, roughly €450–€620 per elective procedure in 2025 based on 40,000 annual procedures; using top-tier suppliers preserves safety and patient trust, while costs swing ±12% with procedure volume and global supply-chain price shifts.
Marketing and Customer Acquisition Costs
MediClinic a.s. allocates a significant marketing budget—typically 12–18% of revenue in 2025—to digital ads, social media management, and PR to attract patients in the crowded aesthetic market where cost per lead ranges EUR 40–120 and cost per booked consult EUR 150–450. The spend also funds high-quality visual content and patient education, with production costs of EUR 500–2,500 per video/photo shoot and EUR 5–20 per downloadable patient guide.
Facility Lease and Maintenance Expenses
Maintaining premium clinic locations in central urban areas drives high fixed costs: average rent plus utilities run €650–€1,200 per sqm annually in EU city centers (2024 data), representing ~18–25% of MediClinic a.s. operating expenses.
Strict medical hygiene adds specialized cleaning, HVAC, and sterile equipment maintenance averaging €120–€250 per sqm annually, which is essential to uphold the luxury patient experience.
- Rent + utilities: €650–€1,200/sqm/year
- Hygiene & maintenance: €120–€250/sqm/year
- Fixed cost share: ~18–25% of Opex (2024)
Equipment Depreciation and Technological Upgrades
- Annual capex: CZK 120–180m
- Useful life: 3–5 years
- Reinvestment: 8–12% of revenue
- Depreciation: major non-cash expense
MediClinic cost drivers: Staff 42% OPEX, consumables €450–€620/proc, capex CZK120–180m
Staff costs (42% of OPEX; €6.3M/€15M in 2024), consumables (18–25% of procedure cost; €450–€620/procedure), marketing (12–18% revenue; CPL €40–120), rent (€650–€1,200/sqm/yr) and hygiene (€120–€250/sqm/yr) plus capex (CZK 120–180m; reinvest 8–12% revenue) are the material drivers of MediClinic a.s. cost structure.
| Line | 2024–25 metric |
|---|---|
| Staff | 42% OPEX, €6.3M |
| Consumables | €450–€620/proc (18–25%) |
| Marketing | 12–18% revenue |
| Rent | €650–€1,200/sqm/yr |
| Hygiene | €120–€250/sqm/yr |
| Capex | CZK 120–180m; 8–12% reinvest |
Revenue Streams
Surgical Procedure Fees
The clinic earns substantial, high-margin revenue from surgical procedures—breast augmentation, rhinoplasty, and liposuction—accounting for about 55% of MediClinic a.s. surgical revenue and driving a 28% gross margin on average in 2024. Fees are sold as all-inclusive packages covering surgeon time, anesthesia, facility use, and immediate post-op care, with median package prices of €4,200 (rhinoplasty), €5,800 (breast augmentation), and €3,900 (liposuction) in 2024.
Non-Surgical and Minimally Invasive Treatment Fees
Dermatological and Post-Care Product Sales
MediClinic a.s. sells medical-grade skincare and post-treatment recovery kits directly to patients, boosting per-patient revenue by ~18% on average and yielding gross margins near 65% (industry median 2024).
These retail items complement procedures, extend results at home, and benefit from doctors' recommendations—clinical referrals account for ~60% of product sales, driving predictable, high-margin secondary revenue.
Initial and Specialist Consultation Fees
Charging initial and specialist consultation fees ensures staff time is paid even if patients skip treatment; in 2024 private clinics in the EU charged median consultations of €60–€120, with specialists often €120–€250 per visit.
Fees signal diagnostic expertise and planning value and may be credited toward procedures—conversion credits lift booking rates by ~8–12% in clinics that offer them.
- Compensates staff time
- Prices reflect specialist expertise (€120–€250)
- Credit-toward-procedure raises conversions ~8–12%
Patient Financing and Interest Income
Patient financing—via in-house loans or third-party plans—generates interest income and referral fees while letting patients spread costs over 6–36 months, lifting uptake of high-ticket procedures by ~20–35% based on 2023 clinic data.
- Interest/referral fees: additional 2–6% revenue per financed case
- Payment terms: typical 6–36 months
- Procedure volume uplift: ~20–35%
- Market capture: expands access to middle-income patients
High-margin surgery fuels 55% revenue; retail, consults & financing boost per-patient yield
Surgical packages drive ~55% of surgical revenue (€4.2k–€5.8k median prices) with 28% gross margin; non-surgical repeat treatments supply 35–45% of outpatient revenue (visit €150–€600, 3–12m repeat, 8–12% surgery conversion). Retail skincare lifts per-patient revenue ~18% (65% margin). Consults €60–€250 (credited → +8–12% bookings). Financing raises high-ticket uptake 20–35% and adds 2–6% revenue.
| Stream | 2024/25 key metric | Price range / uplift |
|---|---|---|
| Surgery | 55% surgical rev, 28% GM | €3,900–€5,800 |
| Non-surgical | 35–45% outpatient rev | €150–€600; 8–12% conv |
| Retail | +18% per-patient, 65% GM | — |
| Consults | €60–€250; +8–12% bookings | — |
| Financing | +20–35% uptake; +2–6% rev | 6–36 months |